Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis

Nephrology

Volumn 20, Issue 1, 2015, Pages 11-17

  Bazzi, Claudio ^a   Stivali, Gilda ^b   Rachele, Gregorio ^b   Rizza, Virginia ^c   Casellato, Daniela ^c   Nangaku, Masaomi ^d  

^a D'Amico Foundation for Renal Diseases Research   (Italy)

^b Baxter SPA   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

arterial hypertension; arteriolar hyalinosis; interstitial hypoxia; tubulo interstitial damage markers

Indexed keywords

ADULT; ARTERIOLAR HYALINOSIS; ARTICLE; BLOOD FLOW; FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HYALINE DEGENERATION; HYPERTENSION; HYPOXIA; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY INTERSTITIUM; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; TUBULO INTERSTITIAL DAMAGE; ANOXIA; ARTERIOLE; COMPLICATION; DIARRHEA; EYE DISEASES, HEREDITARY; INTESTINAL DISEASES; KIDNEY; SKIN ABNORMALITIES; VASCULAR DISEASES; VASCULARIZATION;

ADULT; ANOXIA; ARTERIOLES; DIARRHEA; EYE DISEASES, HEREDITARY; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; HYPERTENSION; INTESTINAL DISEASES; KIDNEY; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SKIN ABNORMALITIES; VASCULAR DISEASES;

EID: 84919705020     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12339     Document Type: Article

References (25)

1. Risdon RA, Sloper JC, de Wardener HE,. Relationship between renal function and histologic changes found in renal-biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968; 2: 363-366.
2. Cravedi P, Remuzzi G,. Pathophysiology of proteinuria and its value as outcome measure in CKD. Br. J. Clin. Pharmacol. 2013; 13: 1159-1167.
3. Ruggenenti P, Cravedi P, Remuzzi G,. Mechanism and treatment of CKD. J. Am. Soc. Nephrol. 2012; 23: 1917-1928.
4. Nangaku M,. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern. Med. 2004; 43: 9-17.
5. Nangaku M,. Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 2006; 17: 17-25.
6. Nangaku M, Inagi R, Miyata T, Fujita T,. Angiotensin-induced hypoxia in the kidney: Functional and structural changes of the renal circulation. Adv. Exp. Med. Biol. 2007; 618: 85-99.
7. Nangaku M, Inagi R, Miyata T, Fujita T,. Hypoxia and hypoxia-inducible factor in renal disease. Nephron Exp. Nephrol. 2008; 110: e1-e7.
8. Tanaka T, Nangaku M,. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2010; 19: 43-50.
9. Mimura I, Nangaku M,. The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease. Nat. Rev. Nephrol. 2010; 6: 667-678.
10. Tsutomu I, Kozawa E, Okada H, et al. Non-invasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J. Am. Soc. Nephrol. 2011; 22: 1429-1434.
11. Nangaku M, Rosenberger C, Heyman SN, Eckardt KU,. Regulation of hypoxia-inducible factor in kidney disease. Clin. Exp. Pharmacol. Physiol. 2013; 40: 148-157.
12. Nangaku M, Fujita T,. Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens. Res. 2008; 31: 175-184.
13. Bazzi C, Petrini C, Rizza V, et al. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephopathy. J. Nephrol. 2009; 22: 387-396.
14. D'Amico G, Ferrario F, Colasanti G, Ragni A, Bestetti Bosisio M,. IgA-mesangial nephropathy (Berger's disease) with rapid decline in renal function. Clin. Nephrol. 1981; 16: 251-257.
15. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009; 150: 604-612.
16. Bazzi C, Petrini C, Rizza V, et al. Urinary N-acetyl-β-glucosaminidase excretion is a marker of tubular cell dysfunction and predictor of outcome in primary glomerulonephritis. Nephrol. Dial. Transplant. 2002; 17: 1890-1896.
17. Bazzi C, Petrini C, Rizza V, et al. Urinary excretion of IgG and α1-microglobulin predict clinical course better than extent of proteinuria in membranous nephropathy. Am. J. Kidney Dis. 2001; 38: 240-248.
18. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G,. Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: Clinical significance and prognostic value of low molecular weight 'tubular' proteins. Am. J. Kidney Dis. 1997; 29: 27-35.
19. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM,. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am. J. Physiol. 1981; 241 (1): F85-F93.
20. Bazzi C, Rizza V, Casellato D, et al. Validation of some pathophysiological mechanisms of the CKD progression and outcome prediction in IgA nephropathy. J. Nephrol. 2012; 25: 810-818.
21. Gouva C, Nikolopoulos P, Ioannidis IP, Siamopoulos KC,. Treating anemia early in renal failure patients slows the decline of renal function. Kidney Int. 2004; 66: 753-760.
22. Norman JT, Stidwill R, Singer M, Fine LG,. Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel potential renoprotective action. Nephron Physiol. 2003; 94: 39-46.
23. Eto N, Kojima I, Uesugi N, et al. Protection of endothelial cells by dextran sulfate in rats of thrombotic microangiopathy. J. Am. Soc. Nephrol. 2005; 16: 2997-3005.
24. Tanaka T, Nangaku M,. Angiogenesis and hypoxia in the kidney. Nat. Rev. Nephrol. 2013; 9: 211-222.
25. Mimura I, Tanaka T, Nangaku M,. Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis. Semin. Nephrol. 2013; 33: 375-382.